Contemporary prevalence of carotid stenosis in patients presenting with ischaemic stroke

Carotid stenosis is a common cause of ischaemic stroke and transient ischaemic attack (TIA). Despite rising recognition and centralization of stroke services there has been a decline in interventions for carotid stenosis in recent years. The aim of this study was to determine the current prevalence and management of carotid stenosis in the UK.

[1]  R. Sidaginamale,et al.  Getting it right first time (GIRFT): A closed loop study of hip arthroplasty documentation in a trauma and orthopaedic department , 2020, Annals of medicine and surgery.

[2]  B. Linden.  National Institute for Health and Care Excellence NG128 stroke and transient ischaemic attack in over 16s: diagnosis and initial management , 2020, British Journal of Cardiac Nursing.

[3]  R. Conwit,et al.  Clopidogrel and Aspirin in Acute Ischemic Stroke and High‐Risk TIA , 2018, The New England journal of medicine.

[4]  J. Bosch,et al.  Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial. , 2018, Lancet.

[5]  Nick Sevdalis,et al.  Successful strategies in implementing a multidisciplinary team working in the care of patients with cancer: an overview and synthesis of the available literature , 2018, Journal of multidisciplinary healthcare.

[6]  S. Sacco,et al.  Distribution and Temporal Trends From 1993 to 2015 of Ischemic Stroke Subtypes: A Systematic Review and Meta-Analysis , 2018, Stroke.

[7]  R. Fleetcroft,et al.  Variations in statin prescribing for primary cardiovascular disease prevention: cross-sectional analysis , 2014, BMC Health Services Research.

[8]  Catherine Perry,et al.  Impact of centralising acute stroke services in English metropolitan areas on mortality and length of hospital stay: difference-in-differences analysis , 2014, BMJ : British Medical Journal.

[9]  Secondary Primary.  Sentinel Stroke National Audit Programme (SSNAP) , 2014 .

[10]  G. Lanzino,et al.  Asymptomatic carotid artery stenosis: time to rethink our therapeutic options? , 2014, Neurosurgical focus.

[11]  J. Potter,et al.  Changes in antiplatelet use prior to incident ischaemic stroke over 7 years in a UK centre and the association with stroke subtype. , 2013, Age and ageing.

[12]  J. Broderick,et al.  Carotid Artery Stenosis as a Cause of Stroke , 2012, Neuroepidemiology.

[13]  A. Naylor,et al.  Time to rethink management strategies in asymptomatic carotid artery disease , 2012, Nature Reviews Cardiology.

[14]  P. Nederkoorn,et al.  Ethnicity a risk factor? The relation between ethnicity and large‐ and small‐vessel disease in White people, Black people, and Asians within a hospital‐based population , 2009, European journal of neurology.

[15]  H. Vorum,et al.  Vascular Society of Great Britain and Ireland , 2008 .

[16]  J. Farmer.  High-dose atorvastatin after stroke or transient ischemic attack. , 2007, Current atherosclerosis reports.

[17]  M. Hennerici,et al.  High-dose atorvastatin after stroke or transient ischemic attack. , 2006, The New England journal of medicine.

[18]  S. Gutnikov,et al.  From subgroups to individuals: general principles and the example of carotid endarterectomy , 2005, The Lancet.

[19]  曲东锋.  Stroke Prevention by Aggressive Reduction in Cholesterol Levels , 2004 .

[20]  S. A. Gutnikov,et al.  Reanalysis of the Final Results of the European Carotid Surgery Trial , 2003, Stroke.

[21]  Olaf Gefeller,et al.  Epidemiology of Ischemic Stroke Subtypes According to TOAST Criteria: Incidence, Recurrence, and Long-Term Survival in Ischemic Stroke Subtypes: A Population-Based Study , 2001, Stroke.

[22]  C. Warlow,et al.  Prediction of benefit from carotid endar terectomy in individual patients: a risk-modelling study , 1999, The Lancet.

[23]  P. Rothwell,et al.  Prediction of benefit from carotid endarterectomy in individual patients: a risk-modelling study. European Carotid Surgery Trialists' Collaborative Group. , 1999, Lancet.

[24]  D. Sackett,et al.  Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. , 1998, The New England journal of medicine.

[25]  J. Slattery,et al.  Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST) , 1998, The Lancet.

[26]  David Lee Gordon,et al.  Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.

[27]  D. Sackett,et al.  Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. , 1991, The New England journal of medicine.

[28]  L. Wilkins.  North American Symptomatic Carotid Endarterectomy Trial. Methods, patient characteristics, and progress. , 1991, Stroke.

[29]  E. Feldmann,et al.  Chinese‐white differences in the distribution of occlusive cerebrovascular disease , 1990, Neurology.

[30]  Daniel B Hier,et al.  The Stroke Data Bank: design, methods, and baseline characteristics. , 1988, Stroke.